Cargando…
Association between preoperative serum Cystatin‐C levels and postsurgical oncological prognosis in patients with PRCC: A retrospective cohort study
OBJECTIVE: Cystatin‐C (Cys‐C) is a predictor of several malignancies. However, whether Cys‐C levels predict prognosis in patients with papillary renal cell carcinoma (PRCC) remains uncertain. The aim of this study was to assess the correlation between Cys‐C and clinical outcomes in patients with PRC...
Autores principales: | Lu, Shiyang, Li, Shijie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678088/ https://www.ncbi.nlm.nih.gov/pubmed/35384340 http://dx.doi.org/10.1002/cam4.4731 |
Ejemplares similares
-
FBA-PRCC. Partial Rank Correlation Coefficient (PRCC) Global Sensitivity Analysis (GSA) in Application to Constraint-Based Models
por: Sorokin, Anatoly, et al.
Publicado: (2023) -
Preoperative serum cystatin-C as a potential biomarker for prognosis of renal cell carcinoma
por: Guo, Shengjie, et al.
Publicado: (2017) -
PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue
por: Xiong, Lei, et al.
Publicado: (2017) -
Prognostic value of preoperative serum cystatin-C level for non-metastatic renal cell carcinoma—correspondence
por: Tang, Yaxiong, et al.
Publicado: (2023) -
Reference Intervals for Serum Cystatin C and Factors Influencing Cystatin C Levels Other than Renal Function in the Elderly
por: Wei, Lu, et al.
Publicado: (2014)